Akums Drugs IPO Subscription
The Akums Drugs IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Employees.
As per the latest subscription update, the Akums Drugs IPO has received bids for 96,36,79,134 shares against 1,51,62,239 shares offered, resulting in an overall subscription of 63.56x. the NII category is subscribed 42.21x, Retail Investors 21.3x, Employees 4.27x, and QIBs 90.09x. Within the NII category, BNII is subscribed 47.43x, while SNII is subscribed 31.78x.
Subscription Highlights
- Overall Subscription: 63.56x
- QIB Subscription: 90.09x
- NII Subscription: 42.21x
- BNII Subscription: 47.43x
- SNII Subscription: 31.78x
- Retail Subscription: 21.3x
- Employee Subscription: 4.27x
- Retail
- 21.3x
- NII
- 42.21x
- QIB
- 90.09x
- Total
- 63.56x
Current GMP
₹43 (+6.33%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Akums Drugs IPO Subscription Details ( Sat, 24 Aug 24 07:34 AM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 8,137,276 | 733,117,770 | 90.09x |
| Non-Institutional | 4,068,637 | 171,750,128 | 42.21x |
| BNII (>₹10L) | 2,712,425 | 128,649,664 | 47.43x |
| SNII (₹2L–₹10L) | 1,356,212 | 43,100,464 | 31.78x |
| Retail Investors | 2,712,424 | 57,770,020 | 21.3x |
| Employees | 243,902 | 1,041,216 | 4.27x |
| Total | 15,162,239 | 963,679,134 | 63.56x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup
| Category | Reserved | Applied | Times (x) |
|---|---|---|---|
| Non-Institutional | 0 | 0 | 0x |
| BNII (>₹10L) | 0 | 0 | 0x |
| SNII (₹2L–₹10L) | 0 | 0 | 0x |
| Retail Investors | 0 | 0 | 0x |
| Employees | 0 | 0 | 0x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Akums Drugs IPO Live Subscription Status?
You can check the Akums Drugs IPO live subscription status on the IPO Master App or the official websites of the NSE,BSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Akums Drugs IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Akums Drugs IPO was subscribed 21.3 times as of Sat, Aug 24, 2024 01:04 PM. The public issue closed on Thu, Aug 1, 2024 for bidding.
How to subscribe Akums Drugs IPO?
Investors can apply for the Akums Drugs IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Akums Drugs IPO subscribed?
The Akums Drugs IPO was subscribed 63.56x times at the close of bidding period on Thu, Aug 1, 2024.
How to check Akums Drugs IPO allotment?
The Akums Drugs IPO allotment was finalized on Fri, Aug 2, 2024. You can check the Akums Drugs IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Akums Drugs IPO Be Listed?
The Akums Drugs IPO was listed on Tue, Aug 6, 2024, on the NSE,BSE.
What is the Akums Drugs IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Akums Drugs IPO was subscribed 90.09 times as of Sat, Aug 24, 2024 01:04 PM.